Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
A metabolite produced by the gut microbiota increases the risk of colon cancer in mice prone to the disease, a new study has found.
Gut microbiota could make the anti-diabetic drug metformin less effective, researchers from the University of Gothenburg have found.
Researchers have found that skin microbiota plays a key role in wound-healing processes.
Researchers have found that the development of liver cancer can be associated with alterations of the gut microbiota.
A study published in Science Advances suggests that optimizing the gut microbiota can inhibit the development of Alzheimer’s disease.
Researchers have identified the factors that influence the composition of the urinary microbiota in older women.
A new study evaluates the association of multiple breast milk feeding practices with infant gut microbiota composition during a baby’s first year.
A new study, published in Cell Metabolism, identified a microbial signature that is able to diagnose cirrhosis in people.
Researchers have found that alterations in the gut microbiota composition in prediabetic people could contribute to type 2 diabetes.
A study published in Nature could help to determine how intestinal motility is regulated and understand systemic disorders related to the gut-brain axis.
